Skip Ribbon Commands
Skip to main content

Ibrutinib

Drug Class: Commonly Known As: Category:
Bruton Tyrosine Kinase Inhibitor Imbruvica® Cancer-related

Ibrutinib - What is it for

Ibrutinib is a targeted medicine used in the treatment of Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia and Waldenström’s Macroglobulinemia.

Ibrutinib - Additional Information

Updated on Thursday, February 28, 2019

This article is contributed by Department of Pharmacy National Cancer Centre Singapore

    The information provided is not intended as medical advice. Terms of use. Information provided by SingHealth

    ​​

    Medication Search